Cantor Fitzgerald Reiterates Overweight Rating on AxoGen (AXGN)

March 11, 2022 6:08 AM EST Send to a Friend
Cantor Fitzgerald analyst Ross Osborn reiterated an Overweight rating and $21.00 price target on AxoGen, Inc. (NASDAQ: AXGN). The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login